Am J Transplant, Volume 21, Suppl 3 Archives - Page 136 of 139 - ATC Abstracts

2021 American Transplant Congress
COVID-19 in Kidney Transplant Recipients in the Southeastern United States: A Single Center Experience
K. R. Kumm, S. H. Shawar, R. C. Forbes, B. P. Concepcion
Vanderbilt University Medical Center, Nashville, TN
*Purpose: The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or COVID-19, has emerged as a viral pandemic and brought unprecedented challenges worldwide on…
2021 American Transplant Congress
Covid-19 Reinfection in a Kidney Transplant Patient
Z. Saeed Zafar, D. Malhotra
Nephrology, Yale School of Medicine, New Haven, CT
*Purpose: Several cases have demonstrated positive SARS-CoV-2 PCR testing in patients who were initially shown to have cleared the infection. These reinfections may represent new…
2021 American Transplant Congress
Outcomes Among CMV Mismatched and Highly Sensitized Kidney Transplant Recipients Who Develop Leukopenia or Neutropenia
S. Brar¹, R. Berry², A. Raval³, Y. Tang³, F. Vincenti², N. Skartsis²
¹University of British Columbia, Vancouver, BC, Canada, ²University of California, San Francisco, San Francisco, CA, ³Merck and Co., Inc., Kenilworth, NJ
*Purpose: Kidney transplant recipients (KTRs) who receive antiproliferative agents for immunosuppression and valganciclovir for CMV prophylaxis are at high risk of developing leukopenia and neutropenia.…
2021 American Transplant Congress
Unquantified Blips Lead to CMV Slips – Post Transplant CMV Monitoring in High Risk Kidney Transplant Recipients
A. T. Payne¹, J. G. Timpone², A. Gilbert², B. Thomas², B. K. Lindner²
¹Georgetown University School of Medicine, Washington, DC, ²Medstar Georgetown University Hospital, Washington, DC
*Purpose: Cytomegalovirus (CMV) is a significant cause of morbidity, mortality, and graft failure after solid organ transplantation, with high risk (D+/R-) patients being the highest…
2021 American Transplant Congress
BKV-Associated Urothelial Carcinoma in Patients After Renal and Extrarenal Carcinoma
A. Schwarz¹, J. Schmitz², J. Gottlieb³, C. Bara⁴, H. Haller¹, J. Braesen²
¹Nephrology Department, Hannover Medical School, Hannover, Germany, ²Institute of Pathology, Hannover Medical School, Hannover, Germany, ³Department of Pneumology, Hannover Medical School, Hannover, Germany, ⁴Department of Thoracic Surgery, Hannover Medical School, Hannover, Germany
*Purpose: Polyomavirus BK (BKV) reactivation or transmission is a wellknown problem in renal transplant (TX) patients with BKV nephropathy and interstitial cystitis. The role of…
2021 American Transplant Congress
The Incremental Cost of Transplanting Patients with 100% cPRA Under the Kidney Allocation System: A Single Center Analysis
R. Gumber, E. Kraus, K. Jackson, N. Alachkar
Nephrology, Johns Hopkins University School of Medicine, Baltimore, MD
*Purpose: Our group has described excellent three year patient and graft survival in patients with 100% cPRA undergoing kidney transplantation under the Kidney Allocation System…
2021 American Transplant Congress
The Extremes of KDPI: Even KDPI 95%+ Kidneys Can Be Used Successfully
A. Gilbert, J. Verbesey, B. Thomas, J. Moore, M. Cooper
Medstar Georgetown Transplant Institute, Washington, DC
*Purpose: While the use of kidneys with KDPIs greater than 85% has become common, there is still reluctance among centers to use the very highest…
2021 American Transplant Congress
Donation After Circulatory Death Kidney Transplantation Has Equal Long-Term Graft and Patient Survival as Donation After Brain Death: A Systematic Review and Meta-Analysis
E. Rijkse¹, S. Ceuppens¹, H. Qi², J. N. IJzermans¹, D. A. Hesselink³, R. C. Minnee¹
¹HPB/Transplant surgery, Erasmus Medical Center, Rotterdam, Netherlands, ²Biostatistics, Erasmus Medical Center, Rotterdam, Netherlands, ³Nephrology and Transplantation, Erasmus Medical Center, Rotterdam, Netherlands
*Purpose: Donation after circulatory death (DCD) kidneys are not worldwide accepted yet due to concerns about inferior quality. To investigate whether these concerns are justified,…
2021 American Transplant Congress
True Living Donation Experiences: A Thematic Analysis of Storytelling from Kidney Living Donors
E. Ho¹, E. H. Wood², R. Pines³, L. A. Davis⁴, S. M. Advani⁵, A. D. Waterman²
¹Terasaki Institute, Los Angeles, CA, ²UCLA David Geffen School of Medicine, Los Angeles, CA, ³Cottage Hospital, Santa Barbara, CA, ⁴DeSales University, Center Valley, PA, ⁵National Human Genome Research Institute (NIH), Bethesda, MD
*Purpose: Personal experiences of living donors (LDs) or recipients (Rs) can motivate more individuals to pursue living donor kidney transplant. After building a library of…
2021 American Transplant Congress
Impact of Treatment of Subclinical Rejection at 2 Weeks After Kidney Transplantation, Compared by 1 Year Histologic Outcomes
O. Lee¹, K. Lee¹, J. Park¹, J. Lee², G. Kwon³, K. Kim⁴
¹Surgery, Samsung Medical Center, Seoul, Korea, Republic of, ²Medicine, Samsung Medical Center, Seoul, Korea, Republic of, ³Pathology, Samsung Medical Center, Seoul, Korea, Republic of, ⁴Biostatistics, Samsung Medical Center, Seoul, Korea, Republic of
*Purpose: Subclinical rejection (SCR) is associated with chronic allograft nephropathy, which is the most common cause of allograft failure in kidney transplantation (KT). Therefore, early…